Ariana Pharma – Artificial Intelligence for Precision Medicine

Meet KEM®

Ariana has developed KEM® (Knowledge Extraction and Management) the most advanced Artificial Intelligence platform based on Galois Lattices (also known as Formal Concept Analysis or FCA). KEM® uses association rules to fully explore complex datasets in order to reveal hidden relationships and to derive new hypotheses.

Fast-Track clinical trials
Identify best responders
Spot optimal endpoints

Our approach

Customers

Join the leading global pharma, biotech and healthcare companies who benefit from our expertise.

READ

Partners

Learn more about our international collaborative research and development projects.

BROWSE

Technology

Discover how our KEM® Artificial Intelligence platform provides a unique approach to fully explore complex datasets.

Latest News

711, 2019

Comorbidities play an important role in hospitalized influenza mortality risk, Real World Evidence (RWE) study performed by Ariana and Sanofi Pasteur shows

Big Data analysis of over 125 Million patient hospitalization records using Ariana’s data analytics and AI platform identifies significant factors increasing Case Fatality Rates […]

509, 2019

Towards a first precision medicine Immunotherapy for the treatment of Type 1 Diabetes using Ariana’s Artificial Intelligence

Ariana’s KEM® Artificial Intelligence technology identified immunological changes, which are early indicators of clinical effects, for selected groups of patients in a first-in-human Phase 1b study. The potential for a [...]

2907, 2019

Alzheimer’s Disease/Dementia Early Detection and Precision Medicine Using KEM® Artificial Intelligence (AI): latest research results presented by ARIANA at the AAIC 2019.

Gut Microbiota biomarkers associated with improved drug response, as well as genomic biomarkers for early detection of patients at risk were identified using Ariana’s KEM® Explainable AI (XAI) in 3 [...]

Fast-track your clinical trials

Contact Us

We explore deeper to find the best biomarkers

Our KEM® platform is the only FDA-tested technology that explores the entire combinatorial space, and guides you to the most cost-effective biomarkers.

We look closer to maximize clinical trial success rates

Our FDA-tested KEM® technology helps secure product approval .

We discover more with KEM®

KEM®, our Artificial Intelligence, finds hidden signals and complex relationships that conventional statistical analyses miss.

We Fast-track your clinical trials

We identify best Responders and optimal Endpoints.